RT @PRO_ON_Dk: First study to define and test a PRO item set to assess weekly symptomatic AEs related to primary pelvic #radiotherapy inclu…
RT @PRO_ON_Dk: First study to define and test a PRO item set to assess weekly symptomatic AEs related to primary pelvic #radiotherapy inclu…
RT @PRO_ON_Dk: First study to define and test a PRO item set to assess weekly symptomatic AEs related to primary pelvic #radiotherapy inclu…
RT @PRO_ON_Dk: First study to define and test a PRO item set to assess weekly symptomatic AEs related to primary pelvic #radiotherapy inclu…
RT @PRO_ON_Dk: First study to define and test a PRO item set to assess weekly symptomatic AEs related to primary pelvic #radiotherapy inclu…
RT @PRO_ON_Dk: First study to define and test a PRO item set to assess weekly symptomatic AEs related to primary pelvic #radiotherapy inclu…
RT @PRO_ON_Dk: First study to define and test a PRO item set to assess weekly symptomatic AEs related to primary pelvic #radiotherapy inclu…
First study to define and test a PRO item set to assess weekly symptomatic AEs related to primary pelvic #radiotherapy including MR guided RT Important work by @krause_moeller and @Helle_PP 🙂👏 https://t.co/cI9Pc0Dhqf
Development of patient-reported outcomes item set to evaluate acute treatment toxicity to pelvic online magnetic resonance-guided radiotherapy https://t.co/FF0sI1j8zk
Development of patient-reported outcomes item set to evaluate acute treatment toxicity to pelvic online magnetic resonance-guided radiotherapy https://t.co/w35KeHUbaR
Development of patient-reported outcomes item set to evaluate acute treatment toxicity to pelvic online magnetic resonance-guided radiotherapy https://t.co/4dS8BOrbXB
New article: Development of patient-reported outcomes item set to evaluate acute treatment toxicity to pelvic online magnetic resonance-guided radiotherapy https://t.co/rdOQHFb42R #prostatecancer #oncology https://t.co/eQcGgQquHM